Board Meeting21 Oct 2026, 05:10 pm
Alivus Life Sciences Board Meeting on Oct 29 to Approve Unaudited Financials
AI Summary
Alivus Life Sciences Ltd has announced that its Board of Directors will convene on October 29, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. In line with SEBI regulations on insider trading, the company has also declared a trading window closure for designated persons from October 1, 2026, to October 31, 2026, to prevent potential misuse of information related to the financial results.
Key Highlights
- Board meeting scheduled for October 29, 2026.
- To approve unaudited financial results for Q2 FY27 and H1 FY27.
- Trading window closed from October 1 to October 31, 2026.
- Purpose is to prevent insider trading related to financial results.
Price Impact
More from ALIVUS